EUVIMEDObjevte EUVIMED
Crossref

Interorganizational Accounting: The Role of BRSR in Driving Accountability of Pharmaceutical Supply Chain

Kali Charan Sabat, Ashu Sharma, Anju Singh, Bala Krishnamoorthy

Business Strategy and the Environment · 2026-11-18

DOI: 10.1002/bse.71864 ↗

At a glance

Journal article in Business Strategy and the Environment, published online on 2026-11-18. Written by Kali Charan Sabat and 3 co-authors. 61 references.

AbstraktBibliografické údajeCiteRelated studies

Abstract (original language)

Pharmaceutical supply chains are significant players contributing to the economy of a nation. This has resulted in widespread pollution of the environment, harming both human health and the ecosystem. This study examines the business responsibility and sustainability reporting (BRSR) disclosures of 59 Indian pharmaceutical businesses (ranked in the top 1000 by 2025). The research employs a systematic process that includes data extraction using automation tools and analysis with Python libraries. The examination looks at a variety of topics, including product focus, operational efficiency, environmental performance, employees' demographics, and stakeholder involvement. The findings demonstrate differences in environmental, social, and governance (ESG) performance among organizations. As the study is on pharmaceutical companies, it also examines the attributes embedded in Good Manufacturing Practices (a system of rules and guidelines). To explain the phenomenon, the authors integrated insights from the resource‐based view and institutional theory. This research study has integrated interpretive structural modelling with structural equation modelling to identify the good manufacturing practices (GMP) drivers and enablers. The study was conducted at two levels. In the first level, experts were interviewed to understand the interrelationship between drivers and BRSR practices. In the second level, an interpretive structural model was developed, and the identified relationships were tested using structural equation modelling. The results revealed that regulatory pressure and competition were the key drivers for good manufacturing practices. This research provides significant insights for investors, policymakers, and the pharmaceutical sector as a whole in navigating the complicated terrain of sustainability reporting and making meaningful progress towards ESG goals.

Cite

APA

Sabat, K. C., Sharma, A., Singh, A., & Krishnamoorthy, B. (2026). Interorganizational Accounting: The Role of BRSR in Driving Accountability of Pharmaceutical Supply Chain. Business Strategy and the Environment. https://doi.org/10.1002/bse.71864

Vancouver

Sabat KC, Sharma A, Singh A, Krishnamoorthy B. Interorganizational Accounting: The Role of BRSR in Driving Accountability of Pharmaceutical Supply Chain. Business Strategy and the Environment. 2026. doi:10.1002/bse.71864

BibTeX
@article{Sabat2026,
  author = {Sabat, Kali Charan and Sharma, Ashu and Singh, Anju and Krishnamoorthy, Bala},
  title = {Interorganizational Accounting: The Role of BRSR in Driving Accountability of Pharmaceutical Supply Chain},
  journal = {Business Strategy and the Environment},
  year = {2026},
  doi = {10.1002/bse.71864}
}
Start for free →